Aileron Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ALRN and buy or sell other stocks, ETFs, and their options commission-free!

About ALRN

Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers. 

CEO
Brian J. Windsor, PhD
CEOBrian J. Windsor, PhD
Employees
11
Employees11
Headquarters
Austin, Texas
HeadquartersAustin, Texas
Founded
2001
Founded2001
Employees
11
Employees11

ALRN Key Statistics

Market cap
93.81M
Market cap93.81M
Price-Earnings ratio
-0.55
Price-Earnings ratio-0.55
Dividend yield
—
Dividend yield—
Average volume
31.64K
Average volume31.64K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$5.00
52 Week high$5.00
52 Week low
$1.35
52 Week low$1.35
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.